A carregar...
P10.04 Anti-angiogenetic Therapy with Bevacizumab for Gliomas with a Gliomatosis Cerebri Growth Pattern
Anti-angiogenetic therapy is widely used in patients with glioma in the relapse situation. In glioblastoma and glioma, bevacizumab has been shown to have an impact on progression-free survival and neurologic function, but not on overall survival. However, its use on patients with gliomas showing a g...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463866/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.322 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|